Pambid MR - Search Results

1

RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer.

Huynh MM, Jayanthan A, Pambid MR, Los G, Dunn SE. Huynh MM, et al. Among authors: pambid mr. Expert Opin Ther Targets. 2020 Jan;24(1):1-5. doi: 10.1080/14728222.2020.1709824. Epub 2019 Dec 27. Expert Opin Ther Targets. 2020. PMID: 31875730 No abstract available.

2

The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials.

Huynh MM, Pambid MR, Jayanthan A, Dorr A, Los G, Dunn SE. Huynh MM, et al. Among authors: pambid mr. Expert Opin Investig Drugs. 2020 Nov;29(11):1199-1208. doi: 10.1080/13543784.2020.1818067. Epub 2020 Sep 17. Expert Opin Investig Drugs. 2020. PMID: 32869671 Review.

3

Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma.

Pambid MR, Berns R, Adomat HH, Hu K, Triscott J, Maurer N, Zisman N, Ramaswamy V, Hawkins CE, Taylor MD, Dunham C, Guns E, Dunn SE. Pambid MR, et al. Pediatr Blood Cancer. 2014 Jan;61(1):107-15. doi: 10.1002/pbc.24675. Epub 2013 Aug 12. Pediatr Blood Cancer. 2014. PMID: 23940083

4

Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.

Triscott J, Lee C, Foster C, Manoranjan B, Pambid MR, Berns R, Fotovati A, Venugopal C, O'Halloran K, Narendran A, Hawkins C, Ramaswamy V, Bouffet E, Taylor MD, Singhal A, Hukin J, Rassekh R, Yip S, Northcott P, Singh SK, Dunham C, Dunn SE. Triscott J, et al. Among authors: pambid mr. Cancer Res. 2013 Nov 15;73(22):6734-44. doi: 10.1158/0008-5472.CAN-12-4331. Epub 2013 Sep 9. Cancer Res. 2013. PMID: 24019381

5

YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.

Davies AH, Reipas KM, Pambid MR, Berns R, Stratford AL, Fotovati A, Firmino N, Astanehe A, Hu K, Maxwell C, Mills GB, Dunn SE. Davies AH, et al. Among authors: pambid mr. Stem Cells. 2014 Jun;32(6):1437-50. doi: 10.1002/stem.1707. Stem Cells. 2014. PMID: 24648416 Free PMC article.

6

Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.

Triscott J, Lee C, Hu K, Fotovati A, Berns R, Pambid M, Luk M, Kast RE, Kong E, Toyota E, Yip S, Toyota B, Dunn SE. Triscott J, et al. Oncotarget. 2012 Oct;3(10):1112-23. doi: 10.18632/oncotarget.604. Oncotarget. 2012. PMID: 23047041 Free PMC article.

7

YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification.

Davies AH, Barrett I, Pambid MR, Hu K, Stratford AL, Freeman S, Berquin IM, Pelech S, Hieter P, Maxwell C, Dunn SE. Davies AH, et al. Among authors: pambid mr. Oncogene. 2011 Aug 25;30(34):3649-60. doi: 10.1038/onc.2011.82. Epub 2011 Mar 21. Oncogene. 2011. PMID: 21423216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters